Sector consensus Johnson & Johnson

Equities

Real-time Estimate Cboe BZX Other stock markets 17:30:03 16/03/2026 GMT			5-day change	1st Jan Change
243.02 ^USD	+0.62%		+0.08%	+17.32%

12:37pm	Monte Rosa Therapeutics Announces Clinical Supply Agreement to Support Phase 2 Trial Evaluating MRT-2359 in Combination with Apalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer	CI
12:36pm	Nasus Pharma Ltd Announces Positive Top Line Data from Phase 2 Clinical Study of NS002	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
JOHNSON & JOHNSON	238.29	-1.34%	24
ELI LILLY AND COMPANY	1,216.93	+23.54%	29
ABBVIE INC.	248.86	+13.28%	29
ROCHE HOLDING AG	363.47	+13.34%	19
ASTRAZENECA PLC	220.3	+15.73%	21
NOVARTIS AG	151.21	-1.61%	21
MERCK & CO., INC.	127.78	+10.52%	27
AMGEN INC.	350.03	-4.42%	29
GILEAD SCIENCES, INC.	157.43	+8.58%	28
NOVO NORDISK A/S	329.4	+33.33%	22
PFIZER INC.	28.43	+6.94%	26
BRISTOL-MYERS SQUIBB COMPANY	62.36	+5.55%	25
VERTEX PHARMACEUTICALS INCORPORATED	545.5	+16.23%	28
GSK PLC	20.32	+0.06%	20
SANOFI	98.49	+28.93%	23
CHUGAI PHARMACEUTICAL CO., LTD.	9,823.33	+4.93%	15
TAKEDA PHARMACEUTICAL COMPANY LIMITED	5,696.87	+0.42%	15
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	82.39	+49.49%	17
HALEON PLC	4.266	+13.81%	16
Average	1,040.3	+12.49%	23
Weighted average by Cap.	693.56	+11.99%	25